Keyphrases
Cannabidiol
100%
Neuroblastoma
100%
In Vivo Efficacy
100%
Cannabinoids
28%
Invasiveness
28%
Tumor Xenograft
28%
Pharmacological Activities
14%
In Cancer
14%
Cellular Accumulation
14%
In Vitro Activity
14%
New Therapeutic Strategies
14%
Tumor Cells
14%
Apoptotic Effect
14%
Induced Apoptosis
14%
Programmed Cell Death
14%
Anticancer Drugs
14%
Survivor Experience
14%
Cannabis
14%
Morphological Changes
14%
Cell Cycle Distribution
14%
Active Compounds
14%
Antiangiogenic Activity
14%
Multi-organ
14%
Caspase-3 Activation
14%
Non-psychoactive Cannabinoids
14%
Δ9-tetrahydrocannabinol (Δ9-THC)
14%
Solid Cancer
14%
Palliative Care
14%
Folk Medicine
14%
Cytostatic Effect
14%
Neuroblastoma Cells
14%
Human Neuroblastoma
14%
Combined Modality Therapy
14%
Children with Cancer
14%
Neuroblastoma SK-N-SH
14%
SK-N-SH Cells
14%
Anti-neuroblastoma
14%
Annexin V Assay
14%
Medicine and Dentistry
In Vitro
100%
Cannabidiol
100%
Ganglioneuroblastoma
100%
Cannabinoid
42%
Programmed Cell Death
28%
Tumor Xenograft
28%
Malignant Neoplasm
14%
Side Effect
14%
Tumor Cell
14%
Cannabis
14%
Caspase 3
14%
Sequela
14%
Medicine
14%
Neuroblastoma Cell
14%
Cell Cycle
14%
Anticarcinogen
14%
Pediatric Cancer
14%
Lipocortin 5
14%
Tetrahydrocannabinol
14%
Symptomatic Treatment
14%
Antiangiogenic Activity
14%
Cytostatic Agent
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabidiol
100%
Neuroblastoma
100%
Neoplasm
42%
Cannabinoid
42%
Malignant Neoplasm
28%
Caspase 3
14%
Side Effect
14%
Cannabis
14%
Programmed Cell Death
14%
Antiangiogenic
14%
Anticarcinogen
14%
Lipocortin 5
14%
Tetrahydrocannabinol
14%
Cytostatic Agent
14%